| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |